Showing results (161-170 of 261) with videos related to
Sort By:
Pageof 27
Journal of Women'S Health (2002)|June 10, 2008
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?Todd M Brown, Dhananjay Vaidya, William J Rogers, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 4, 2024
The effect of liver surgery and fluid strategy on renin activity and aldosterone and anti-diuretic hormone levels: a secondary analysis of the GALILEO trialPeter Klompmaker, Timothy H Mungroop, Iris Jongerius, et al.Journal of the American Society of Nephrology : JASN|May 24, 2022
Effects of Short-Term Potassium Chloride Supplementation in Patients with CKDMartin Gritter, Rosa D Wouda, Stanley M H Yeung, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2023
Chronic kidney disease increases the susceptibility to negative effects of low and high potassium intakeMartin Gritter, Kuang-Yu Wei, Rosa D Wouda, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2023
Early Risk Stratification for Natural Disease Course in Fabry Patients Using Plasma Globotriaosylsphingosine LevelsSanne J van der Veen, Mohamed El Sayed, Carla E M Hollak, et al.Journal of Hypertension|May 31, 2021
Hypertension in kidney transplantation: a consensus statement of the 'hypertension and the kidney' working group of the European Society of HypertensionJean-Michel Halimi, Alberto Ortiz, Pantelis A Sarafidis, et al.Pregnancy Hypertension|January 14, 2020
Plasma ceramide is increased and associated with proteinuria in women with pre-eclampsia and HELLP syndromeFouad Amraoui, Hajar Hassani Lahsinoui, Leon J A Spijkers, et al.The American Journal of Cardiology|December 7, 2010
Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials)Paul Frey, David D Waters, David A DeMicco, et al.Current Medical Research and Opinion|October 1, 2010
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2J Wouter Jukema, Cheng-Wen Chiang, Jean Ferrières, et al.American Heart Journal|October 27, 2009
Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2Raul D Santos, David D Waters, Lisa Tarasenko, et al.Pageof 27